share

Etripamil CAS NO 1593673-23-4


Unit Price:

CAS No.:1593673-23-4

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

Etripamil is a novel, investigational calcium channel blocker specifically designed for rapid, patient-administered treatment. This compound is of significant interest for its potential to provide on-demand therapeutic intervention in acute cardiovascular settings. It is primarily targeted at the pharmaceutical research and development sector for the formulation of new drug products.

Application

  • Pharmaceutical R&D: Key intermediate or active pharmaceutical ingredient (API) in the development of novel cardiovascular therapeutics.
  • Clinical Trial Material: Sourcing of high-purity material for Phase I-III clinical studies investigating new treatment paradigms.
  • Mechanistic Studies: Used in preclinical research to study the pharmacology of L-type calcium channel blockade in specific tissues.
  • Formulation Development: Serves as a reference standard or raw material for developing nasal spray or other rapid-delivery dosage forms.
  • Bioanalytical Method Development: Used as a standard for developing and validating HPLC, LC-MS, or other analytical methods for pharmacokinetic studies.
  • Contract Manufacturing: Supplied to CDMOs (Contract Development and Manufacturing Organizations) for scale-up and GMP production.

Basic Information

Product Name Etripamil
CAS No. 1593673-23-4
Molecular Formula C27H30N2O5S
Molecular Weight 494.60 g/mol
Synonyms MSP-2017; (R)-2-(3,4-Dimethoxyphenyl)-5-((2-(3,4-dimethoxyphenyl)ethyl)(methyl)amino)-2-isopropylpentanenitrile; (R)-2-(3,4-Dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile; Gated Calcium Channel Blocker MSP-2017; Etripamil Hydrochloride (salt form precursor)
EINECS Contact for details

Quality Control

Our Etripamil is manufactured and controlled under a strict quality management system. Each batch is subjected to comprehensive analytical testing, including identity confirmation, purity assay, and impurity profiling, to ensure it meets the stringent requirements for pharmaceutical research. A detailed Certificate of Analysis (COA) is provided with each shipment, documenting compliance with agreed specifications.

Storage

Preserve in a tightly closed container, protected from light. Store at controlled room temperature, 15-25°C (59-77°F). The material is hygroscopic (moisture-sensitive) and should be handled in a dry environment to maintain stability.

Specification

Item Specification
Appearance White to off-white solid
Identification (IR) Conforms to reference spectrum
Identification (HPLC) Retention time matches reference standard
Assay (HPLC) ≥98.0%
Related Substances (HPLC) Total impurities ≤2.0% Any single unknown impurity ≤0.5%
Water Content (KF) ≤1.0%
Residue on Ignition ≤0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.